Skip to search formSkip to main contentSkip to account menu

Cytokeratin Fragment 21-1 Measurement

Known as: Cytokeratin 19 Fragment, CYFRA211, Cytokeratin Fragment 21-1 
The determination of the amount of the cytokeratin 19 fragment 21-1 present in a sample.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Introduction To assess whether the value of CYFRA21-1 in the aspirates of ultrasonography-guided fine-needle aspiration biopsy… 
2013
2013
Tumor markers are commonly used to detect a relapse of disease in oncologic patients during follow-up. It is important to… 
2010
2010
The purpose of this study was to investigate clinical–biological factors which could predict the sensitivity to chemoradiotherapy… 
2009
2009
AIM This study aimed to evaluate the accuracy of urine cytology, bladder ultrasound (US), urine cytokeratin 19 fragment assay… 
2007
2007
The aim of this study was to evaluate the individual and combined diagnostic value of five tumour markers in the elderly patients… 
Highly Cited
2003
Highly Cited
2003
BACKGROUND We previously reported that positron emission tomography (PET) with 18-F-fluorodeoxyglucose (FDG) might be a useful… 
2003
2003
Midkine, a heparin-binding growth factor, is expressed in numerous cancer tissues and is reportedly elevated in patients with… 
1999
1999
BACKGROUND The aim was to investigate the diagnostic utility of CYFRA 21-1 (cytokeratin 19 fragment) as a tumor marker in pleural… 
1997
1997
Cytokeratins form part of the cytoskeleton of both normal and malignant epithelium. A novel tumor marker measuring cytokeratin 19…